US Patent Issued to The University of Rochester on Aug. 11 for "Inhibitors of interleukin-1 receptor-associated kinases 1 and 4" (New York Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,698, issued on Aug. 11, was assigned to The University of Rochester (Rochester, N.Y.).

"Inhibitors of interleukin-1 receptor-associated kinases 1 and 4" was invented by Michael Becker (Rochester, N.Y.), Rakesh Singh (Rochester, N.Y.), Richard Moore (Rochester, N.Y.) and Laura Calvi (Rochester, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds that are inhibitors of interleukin-1 receptor-associated kinases 1 and 4 (IRAK1 and IRAK4) and their use in the treatment of medical disorders such as autoimmune disorders, cancer, and pain disorders."

The patent was filed on July 23, 2021, under Application No. 18/0...